SCHEMBL26833595

SCHEMBL26833595

c1ccc2cc(-c3ccc4c(ccc5cc(N(c6ccc(-c7ccc8c(ccc9ccccc98)n7)cc6)c6ccc(-c7ccc8c(ccc9ccccc98)n7)cc6)ccc54)c3)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 1/20 0.39
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ CYP1B1 Q16678 2/20 0.38
▸ CYP1A1 P04798 1/20 0.38
▸ ALDH1A1 P00352 8/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ MAPT P10636 6/20 0.37
▸ HPGD P15428 5/20 0.37
▸ NPC1 O15118 4/20 0.37
▸ RAB9A P51151 4/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ AR P10275 2/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26834067 0.95 BACE1 (0.41) MEN1KMT2ACYP1B1CYP1A1ALDH1A1
SCHEMBL26833679 0.92 CYP3A4 (0.47) SRCKDM4EMAPTNPC1RAB9A
SCHEMBL26833677 0.90 MAPK10 (0.42) SRCALDH1A1KDM4EMAPTHPGD
SCHEMBL26833459 0.90 NPC1 (0.48) SRCMEN1KMT2ACYP1B1CYP1A1
SCHEMBL26833678 0.88 CYP17A1 (0.40) SRCMEN1KMT2AALDH1A1KDM4E
SCHEMBL26833681 0.88 KDM4E (0.40) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL26833848 0.87 NPC1 (0.43) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL26833578 0.87 CYP17A1 (0.36) SRCCYP1B1CYP1A1ALDH1A1KDM4E
SCHEMBL26833481 0.86 NPC1 (0.47) SRCMEN1KMT2AALDH1A1KDM4E
SCHEMBL26834058 0.86 NPC1 (0.47) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357188-A1 PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF AHR, ORAI3, WNT3 SRC 2187/4885MEN1 2016/4885KMT2A 1165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback